Technical Analysis for ACRV - Acrivon Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
50 DMA Support | Bullish | 0.13% | |
Overbought Stochastic | Strength | 0.13% | |
New Uptrend | Bullish | -4.07% | |
Overbought Stochastic | Strength | -4.07% | |
Up 3 Days in a Row | Strength | -4.07% | |
Gapped Down | Weakness | -4.07% | |
Stochastic Reached Overbought | Strength | -3.14% |
Alert | Time |
---|---|
50 DMA Support | about 22 hours ago |
Fell Below Previous Day's Low | about 22 hours ago |
Gap Up Closed | about 23 hours ago |
60 Minute Opening Range Breakdown | about 23 hours ago |
Fell Below 50 DMA | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.9 |
52 Week Low | 3.19 |
Average Volume | 98,122 |
200-Day Moving Average | 7.11 |
50-Day Moving Average | 7.97 |
20-Day Moving Average | 7.74 |
10-Day Moving Average | 8.10 |
Average True Range | 0.35 |
RSI (14) | 54.13 |
ADX | 27.22 |
+DI | 25.33 |
-DI | 13.32 |
Chandelier Exit (Long, 3 ATRs) | 7.41 |
Chandelier Exit (Short, 3 ATRs) | 7.90 |
Upper Bollinger Bands | 8.69 |
Lower Bollinger Band | 6.80 |
Percent B (%b) | 0.64 |
BandWidth | 24.40 |
MACD Line | 0.15 |
MACD Signal Line | 0.10 |
MACD Histogram | 0.0487 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.33 | ||||
Resistance 3 (R3) | 8.33 | 8.23 | 8.27 | ||
Resistance 2 (R2) | 8.23 | 8.15 | 8.23 | 8.25 | |
Resistance 1 (R1) | 8.12 | 8.10 | 8.07 | 8.12 | 8.24 |
Pivot Point | 8.02 | 8.02 | 8.00 | 8.02 | 8.02 |
Support 1 (S1) | 7.91 | 7.94 | 7.86 | 7.91 | 7.78 |
Support 2 (S2) | 7.81 | 7.89 | 7.81 | 7.77 | |
Support 3 (S3) | 7.70 | 7.81 | 7.75 | ||
Support 4 (S4) | 7.70 |